ReviewFrontiers in immunology2026

Immunosenescence shapes the tumor immune microenvironment and limits PD-1/PD-L1 blockade efficacy in older patients with cancer.

Xiaoyu Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.